For help on how to get the results you want, see our search tips.
3 results
Medicine
Maximum residue limits Remove Maximum residue limits filter
Withdrawn applications Remove Withdrawn applications filter
Referrals Remove Referrals filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Referral type
Article 31 referrals Remove Article 31 referrals filter
Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter
Referral PRAC recommendation
Suspension Remove Suspension filter
-
List item
Referral: Paracetamol modified-release
paracetamol, associated names: Alvedon, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2017, EC decision date: 19/02/2018, Last updated: 01/03/2018 -
List item
Referral: Gadolinium-containing contrast agents
gadobenic acid / gadobutrol / gadodiamide / gadopentetic acid / gadoteric acid / gadoteridol / gadoversetamide / gadoxetic acid, associated names: Optimark, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/07/2017, EC decision date: 23/11/2017, Last updated: 04/12/2017 -
List item
Referral: Almitrine-containing medicines
almitrine, associated names: Vectarion, Armanor, Article 31 referrals
Status: CMDh final position, opinion/position date: 29/05/2013, Last updated: 10/06/2013